7-130273096-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001869.3(CPA2):āc.405C>Gā(p.Asn135Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,612,726 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001869.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPA2 | NM_001869.3 | c.405C>G | p.Asn135Lys | missense_variant | 5/11 | ENST00000222481.9 | NP_001860.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPA2 | ENST00000222481.9 | c.405C>G | p.Asn135Lys | missense_variant | 5/11 | 1 | NM_001869.3 | ENSP00000222481.4 | ||
CPA2 | ENST00000416698.1 | n.399C>G | non_coding_transcript_exon_variant | 5/8 | 5 | ENSP00000395582.1 | ||||
CPA2 | ENST00000480781.5 | n.422C>G | non_coding_transcript_exon_variant | 5/5 | 2 | |||||
CPA2 | ENST00000487259.5 | n.420C>G | non_coding_transcript_exon_variant | 5/7 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000835 AC: 21AN: 251464Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135906
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1460528Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 10AN XY: 726670
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2022 | The c.405C>G (p.N135K) alteration is located in exon 5 (coding exon 5) of the CPA2 gene. This alteration results from a C to G substitution at nucleotide position 405, causing the asparagine (N) at amino acid position 135 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at